桂林三金：12月9日召开董事会会议

Group 1 - The core point of the article is that Guilin Sanjin (SZ 002275) held its 16th meeting of the 8th Board of Directors on December 9, 2025, to review various proposals, including the revision and establishment of the "Rules of Procedure for the Audit Committee of the Board" and 19 other systems [1] - For the first half of 2025, Guilin Sanjin's revenue composition was 93.72% from pharmaceuticals and 6.28% from other industries [1] - As of the report date, Guilin Sanjin's market capitalization was 8.8 billion yuan [1]